Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Osteoporosis.

Lee S Simon1

  • 1Harvard Medical School, Beth Isreal Deaconess Hospital, 330 Brookline Avenue, Boston, MA 02215, USA.

Clinics in Geriatric Medicine
|May 25, 2005
PubMed
Summary
This summary is machine-generated.

Understanding bone health is crucial for preventing osteoporosis and fractures. Therapies like bisphosphonates and parathyroid hormone help manage bone loss and reduce fracture risk in vulnerable populations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Validity and utility of a single-item patient-reported measure of treatment-related bother in rheumatoid arthritis: A cross-sectional OMERACT study.

Seminars in arthritis and rheumatism·2026
Same author

The complexity of pain in inflammatory arthropathies beyond pain intensity and impact: An OMERACT initiative.

Seminars in arthritis and rheumatism·2026
Same author

Harm outcomes applicable for most meta-analyses of randomized trials of biomedical interventions: a key concept in clinical epidemiology.

Journal of clinical epidemiology·2026
Same author

Domains for inclusion in a novel Treatment Response Measure for Systemic Lupus Erythematosus (TRM-SLE): results of a modified Delphi study.

Lupus science & medicine·2025
Same author

Slow acting medications for progressive and painful knee osteoarthritis. How do we assess the benefit to risk of these potentially novel therapies?

Osteoarthritis and cartilage open·2024
Same author

Efficacy and safety of a diffusion-based extended-release fluticasone propionate intra-articular injection (EP-104IAR) in knee osteoarthritis (SPRINGBOARD): a 24-week, multicentre, randomised, double-blind, vehicle-controlled, phase 2 trial.

The Lancet. Rheumatology·2024
Same journal

Cardiovascular Prevention in Older Adults: From Estimation to Treatment.

Clinics in geriatric medicine·2026
Same journal

Preventive Cardiology for the Clinically Complex Older Adult.

Clinics in geriatric medicine·2026
Same journal

A Preventive Neurology Perspective on Promoting Brain Health and Preventing Cardiovascular Disease.

Clinics in geriatric medicine·2026
Same journal

Secondary Prevention in Older Adults: Putting It All Together.

Clinics in geriatric medicine·2026
Same journal

Primary Prevention in Older Adults: Putting It All Together.

Clinics in geriatric medicine·2026
Same journal

Managing Bleeding Risk in Older Adults: Antithrombotics and Anticoagulants.

Clinics in geriatric medicine·2026
See all related articles

Area of Science:

  • Orthopedics and Endocrinology
  • Bone Biology and Metabolism

Background:

  • Bone is a dynamic organ crucial for structure and calcium homeostasis.
  • Bone mass naturally changes with age, activity, and body mass.
  • Osteoporosis, or significant bone loss, is a major health concern, particularly in older adults.

Purpose of the Study:

  • To highlight the importance of identifying individuals at risk for bone loss.
  • To review current and emerging therapeutic strategies for managing bone density and fracture risk.

Main Methods:

  • Literature review of bone physiology and osteoporosis management.
  • Analysis of therapeutic efficacy for bisphosphonates and parathyroid hormone.

Main Results:

Related Experiment Videos

  • Bisphosphonates are effective in reducing bone loss and fracture risk.
  • Parathyroid hormone shows potential for greater fracture risk improvement over shorter durations compared to bisphosphonates.

    • Conclusions:

    • Early identification of patients at risk for bone loss is essential.
    • Pharmacological interventions significantly impact bone health and fracture prevention.
    • Emerging therapies offer promising advancements in osteoporosis management.